Core Insights - The rise of Brain-Machine Interfaces (BMI) is becoming a competitive field in Silicon Valley, with companies like Merge Labs and Neuralink leading the charge in innovative technologies [1][40] - Merge Labs, co-founded by Sam Altman, aims to compete with Neuralink by utilizing gene editing and ultrasound technology for non-invasive brain activity decoding [1][40] - The ultrasound BMI technology offers a new approach by reading blood flow signals non-invasively, contrasting with Neuralink's invasive electrode method [1][40] Group 1: Industry Evolution - The concept of BMIs has been around since the 1970s, but significant advancements have occurred in the last decade, with companies like Neuralink emerging [4][12] - Traditional electrical BMIs require electrodes to be implanted in the brain, which can be invasive and limited in scope [4][12] - The complexity of the brain, with its 86 billion neurons, necessitates a more holistic approach to decoding brain activity rather than focusing on isolated regions [5][6] Group 2: Ultrasound BMI Advantages - Ultrasound BMIs can cover a larger area of the brain, potentially imaging 25% of the brain volume compared to Neuralink's 0.13% coverage [17][20] - The time resolution of ultrasound technology is significantly better than fMRI, allowing for near real-time monitoring of blood flow signals [21][22] - Ultrasound BMIs are considered safer as they can be non-invasive, avoiding the risks associated with breaking the dura mater [26][49] Group 3: Clinical Applications - Current applications for ultrasound BMIs include chronic pain management, stroke rehabilitation, and potentially Alzheimer's treatment [32][33] - The technology aims to modulate neural activity through focused ultrasound, which can suppress overactive neurons associated with pain [24][25] - Future applications may extend to mental health disorders, such as depression and anxiety, by targeting specific brain regions [36][38] Group 4: Competitive Landscape - Several companies are emerging in the ultrasound BMI space, including Spire, Nudge, and Forest Neurotech, each focusing on different clinical applications [40][41] - Merge Labs is positioned as a significant player, with a focus on integrating gene therapy with ultrasound technology [40][45] - The competitive landscape indicates a growing interest and investment in non-invasive brain technologies, with potential for rapid advancements in clinical applications [40][41]
挑战Neuralink，硅谷大佬争相涌入的超声脑机接口是什么？
3 6 Ke·2025-10-17 00:55